ImpediMed Limited (IPDQF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 9.99 Million AUD | 8.77% |
| 2023 | 9.19 Million AUD | -69.69% |
| 2022 | 30.32 Million AUD | 1.67% |
| 2021 | 29.82 Million AUD | 0.85% |
| 2020 | 29.57 Million AUD | -0.95% |
| 2019 | 29.85 Million AUD | -11.77% |
| 2018 | 33.84 Million AUD | -3.44% |
| 2017 | 35.04 Million AUD | 15.33% |
| 2016 | 30.38 Million AUD | 62.51% |
| 2015 | 18.69 Million AUD | 84.1% |
| 2014 | 10.15 Million AUD | -8.19% |
| 2013 | 11.06 Million AUD | -26.95% |
| 2012 | 15.14 Million AUD | -13.38% |
| 2011 | 17.48 Million AUD | 27.42% |
| 2010 | 13.72 Million AUD | -12.76% |
| 2009 | 15.72 Million AUD | 37.3% |
| 2008 | 11.45 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | -2.83 Million AUD | 0.0% |
| 2024 Q2 | 4.25 Million AUD | -42.03% |
| 2024 Q3 | -2.83 Million AUD | -166.72% |
| 2024 Q1 | 7.34 Million AUD | 80.88% |
| 2024 FY | 9.99 Million AUD | 8.77% |
| 2023 Q3 | 7.54 Million AUD | 58.29% |
| 2023 Q2 | 4.76 Million AUD | -40.23% |
| 2023 Q1 | 7.97 Million AUD | 90.6% |
| 2023 FY | 9.19 Million AUD | -69.69% |
| 2023 Q4 | 4.05 Million AUD | -46.23% |
| 2022 FY | 30.32 Million AUD | 1.67% |
| 2022 Q1 | 6.65 Million AUD | 22.41% |
| 2022 Q2 | 3.59 Million AUD | -45.94% |
| 2022 Q3 | 7.7 Million AUD | 114.13% |
| 2022 Q4 | 4.18 Million AUD | -45.64% |
| 2021 Q4 | 5.43 Million AUD | -23.9% |
| 2021 Q2 | 5.35 Million AUD | -18.92% |
| 2021 Q1 | 6.6 Million AUD | 49.55% |
| 2021 FY | 29.82 Million AUD | 0.85% |
| 2021 Q3 | 7.14 Million AUD | 33.33% |
| 2020 Q2 | 8.01 Million AUD | 6.34% |
| 2020 Q1 | 7.53 Million AUD | 15.59% |
| 2020 Q3 | 5.17 Million AUD | -35.38% |
| 2020 FY | 29.57 Million AUD | -0.95% |
| 2020 Q4 | 4.41 Million AUD | -14.71% |
| 2019 Q1 | 6.74 Million AUD | -5.45% |
| 2019 Q2 | 6.74 Million AUD | 0.0% |
| 2019 Q4 | 6.52 Million AUD | 0.0% |
| 2019 FY | 29.85 Million AUD | -11.77% |
| 2018 Q3 | 7.13 Million AUD | -9.18% |
| 2018 Q2 | 7.85 Million AUD | 0.0% |
| 2018 Q1 | 7.85 Million AUD | -2.37% |
| 2018 FY | 33.84 Million AUD | -3.44% |
| 2018 Q4 | 7.13 Million AUD | 0.0% |
| 2017 Q4 | 8.04 Million AUD | 0.0% |
| 2017 FY | 35.04 Million AUD | 15.33% |
| 2017 Q2 | 8.04 Million AUD | 0.0% |
| 2017 Q3 | 8.04 Million AUD | 0.03% |
| 2017 Q1 | 8.04 Million AUD | -5.97% |
| 2016 Q1 | 6.61 Million AUD | 23.03% |
| 2016 Q4 | 8.55 Million AUD | 0.0% |
| 2016 Q2 | 6.61 Million AUD | 0.0% |
| 2016 Q3 | 8.55 Million AUD | 29.22% |
| 2016 FY | 30.38 Million AUD | 62.51% |
| 2015 Q1 | 3.82 Million AUD | 32.64% |
| 2015 Q4 | 5.38 Million AUD | 0.0% |
| 2015 FY | 18.69 Million AUD | 84.1% |
| 2015 Q3 | 5.38 Million AUD | 40.84% |
| 2015 Q2 | 3.82 Million AUD | 0.0% |
| 2014 Q3 | 2.88 Million AUD | 20.38% |
| 2014 FY | 10.15 Million AUD | -8.19% |
| 2014 Q2 | 2.39 Million AUD | 0.0% |
| 2014 Q4 | 2.88 Million AUD | 0.0% |
| 2014 Q1 | 2.39 Million AUD | 14.67% |
| 2013 Q3 | 2.08 Million AUD | 0.0% |
| 2013 Q4 | 2.08 Million AUD | 0.0% |
| 2013 FY | 11.06 Million AUD | -26.95% |
| 2012 FY | 15.14 Million AUD | -13.38% |
| 2011 FY | 17.48 Million AUD | 27.42% |
| 2010 FY | 13.72 Million AUD | -12.76% |
| 2009 FY | 15.72 Million AUD | 37.3% |
| 2008 FY | 11.45 Million AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AVITA Medical, Inc. | 80.77 Million USD | 87.623% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -1322.191% |
| Össur hf. | 396.18 Million USD | 97.476% |
| QHSLab, Inc. | 961.65 Thousand USD | -939.668% |
| Wellstar International, Inc. | 1.79 Million USD | -457.086% |
| Össur hf. | 396.18 Million USD | 97.476% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | -90.414% |
| Aurora Spine Corporation | 8.65 Million USD | -15.484% |
| BrainsWay Ltd. | 28.01 Million USD | 64.316% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -1249.848% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 70.22% |
| Vivos Inc. | 2.78 Million USD | -258.723% |
| Kelyniam Global, Inc. | 2.27 Million USD | -339.425% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -885.119% |
| Zecotek Photonics Inc. | 3.46 Million USD | -188.839% |
| Avitar, Inc. | 3.56 Million USD | -180.094% |
| Nanomix Corporation | 8.36 Million USD | -19.483% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 54.091% |
| Theraclion SA | 7.43 Million USD | -34.385% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -892.569% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -221.433% |
| Lombard Medical, Inc. | 30.29 Million USD | 66.992% |
| ALR Technologies Inc. | 6.33 Million USD | -57.797% |
| Stratec SE | 46.32 Million USD | 78.416% |
| Vycor Medical, Inc. | 1.27 Million USD | -683.872% |
| Heart Tronics, Inc. | 14.46 Million USD | 30.858% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.046% |
| VMS Rehab Systems, Inc. | 63.63 USD | -15712614.129% |
| NewCardio, Inc. | 9.56 Million USD | -4.534% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -186.23% |
| Ingen Technologies, Inc. | 1.88 Million USD | -431.181% |
| Odyssey Group International, Inc. | -14.26 Million USD | 170.107% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -2195.752% |
| Wellness Center USA, Inc. | 1.29 Million USD | -672.298% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 29.348% |
| IR-Med Inc. | 4.89 Million USD | -104.291% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -4743.546% |
| Polarean Imaging plc | 12.24 Million USD | 18.333% |
| United American Healthcare Corporation | 59 Thousand USD | -16845.763% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -2353.587% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -8195.306% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -1475.262% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -489.656% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -657.14% |
| Urologix, Inc. | 10.09 Million USD | 0.931% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -691.399% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -68.082% |
| SS Innovations International, Inc. | 21.38 Million USD | 53.241% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -4242.406% |
| Smith & Nephew plc | 3.46 Billion USD | 99.712% |
| NIOX Group Plc | 22.27 Million USD | 55.121% |
| Fuse Medical, Inc. | 10.35 Million USD | 3.401% |
| Broncus Holding Corporation | 38.15 Million USD | 73.794% |
| Brain Scientific Inc. | 9.66 Million USD | -3.47% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 2.96% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -16371.712% |